INCY Trial readout: Tuesday, September 1, 2026
CompanyIncyte Corporation (INCY)
EventTrial readout
DateTuesday, September 1, 2026
MarketUS listing
SourceCT.gov registry · confidence 80% · primary source ↗
Est. Completion: 2026-09-01. Status: ACTIVE_NOT_RECRUITING. Title: Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients
Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.